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Protein complexes represent major functional units for the execution of biological processes.
Systematic afﬁnity puriﬁcation coupled with mass spectrometry (AP-MS) yielded a wealth of
information on the compendium of protein complexes expressed in Saccharomyces cerevisiae.
However, global AP-MS analysis of human protein complexes is hampered by the low throughput,
sensitivity and data robustness of existing procedures, which limit its application for systems
biology research. Here, we address these limitations by a novel integrated method, which we
appliedandbenchmarkedforthehumanproteinphosphatase2Asystem.Weidentiﬁedatotalof197
protein interactions with high reproducibility, showing the coexistence of distinct classes of
phosphatase complexes that are linked to proteins implicated in mitosis, cell signalling, DNA
damage control and more. These results show that the presented analytical process will
substantially advance throughput and reproducibility in future systematic AP-MS studies on
human protein complexes.
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Introduction
The majority of proteins exert an effect in the context of
macromolecular assemblies that are part of dynamic networks
of enormous complexity. Cellular processes, such as cell
signalling, proliferation, apoptosis and cell growth, emerge to
a large extent from the properties of such networks. Hence,
understanding and modelling of cellular processes in healthy
and pathological conditions depend on comprehensive and
robust information on the topology and the dynamic proper-
ties of the engaged protein networks. Initially, large-scale
protein interaction studies were performed with the yeast two-
hybrid technology, which provided insights into global
patterns of binary protein interactions of model organism
proteomes (Uetz et al, 2000; Walhout et al, 2000; Ito et al,
2001). More recently, afﬁnity puriﬁcation coupled with mass
spectrometry (AP-MS) has become the method of choice for
the analysis of protein complexes under near-physiological
conditions (Gingras et al, 2007; Kocher and Superti-Furga,
2007). Large-scale AP-MS studies performed in yeast provided
the ﬁrst comprehensive set of high-density interaction data,
which became an invaluable source of information for yeast
systems biology (Gavin et al, 2002, 2006; Ho et al, 2002;
Krogan et al, 2006). The success in yeast can be mainly
attributed to the high efﬁciency of homologous recombination
that allowed genome-wide tagging of yeast ORFs as a valuable
resource for large-scale AP-MS studies. However, no such
genetic system exists for multicellular eukaryotes.
Given the various cell types and cellular states, each
characterized by speciﬁc protein–protein interaction net-
works, the complexity of the human proteome and the limited
genetic methods available to generate cell lines expressing
afﬁnity-tagged proteins, global analysis of protein complexes
and protein interaction networks in human cells is a daunting
task. Progress towards this goal will strongly depend on
efﬁcient and robust AP-MS workﬂows for human cells that
provide comprehensive as well as high-conﬁdence protein
complex information to populate public databases. The
robustness and reproducibility of such methods are key
because it can be anticipated that data from different studies
and research groups must be combined to achieve saturation
coverage of the human interaction proteome. However, false
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methods, which make the combination of AP-MS data from
differentstudiesdifﬁcult.Inaddition,presentAP-MSstrategies
are limited by the labour-intense generation of large collec-
tions of human cell lines for expression of epitope-tagged bait
proteins, the low yield of protein complex isolation from such
cell lines and the limited sensitivity of MS-based protein
identiﬁcation.
To overcome some of these major limitations, we have
developed an integrated experimental workﬂow. Besides
optimizing each experimental step, we focused on the
compatibility of the steps with each other to generate a
process with improved performance. As a result, the proposed
proceduresigniﬁcantlyenhanced thethroughput ofgenerating
bait-expressing cell lines, increased the protein complex
puriﬁcation yields by a novel double-afﬁnity strategy and
allowed analysis of protein complexes and interaction net-
works with high sensitivity and reproducibility. We applied
this procedure to study a network of human protein
phosphatase 2A (PP2A) complexes. PP2A is a heterotrimeric,
evolutionary conserved serine/threonine phosphatase with
regulatory functions in a wide range of cellular processes,
including transcription, apoptosis, cell growth and cellular
transformation (Virshup, 2000; Lechward et al, 2001). The
human genome encodes two catalytic subunits (PPP2CA,
PPP2CB), two scaffolding subunits (PPP2R1A, PPP2R1B) and
at least 15 known regulatory B subunits that, bycombinatorial
assembly,canpotentiallyformamultitudeofdifferenttrimeric
PP2A complexes (Janssens and Goris, 2001; Lechward et al,
2001). It is believed that the versatile nature of this
combinatorial subunit arrangement provides substrate
speciﬁcity as well as temporal and spatial control of
phosphatase activity. However, no systematic study has yet
been performed to address the question, which PP2A complex
forms indeed coexist in human cells and how these complexes
are connected to speciﬁc cellular processes through protein–
protein interactions. Using the method described in this work,
we identiﬁed 197 speciﬁc protein–protein interactions at a
reproducibility rate of at least 85%. The discovered interac-
tions constitute a network of different classes of concurrently
present phosphatase complexes that in turn are linked to
proteinswithspeciﬁcfunctionsincellsignalling,mitosis,DNA
repair and more.
On the basis of these results, we believe that the proposed
analytical procedure will signiﬁcantly improve the scope and
reproducibility of future AP-MS studies on the human
interaction proteome.
Results
An integrated workﬂow for systematic AP-MS
studies on human protein complexes
Afﬁnity puriﬁcation coupled with mass spectrometry analysis
of protein complexes can be grouped into three sequential
steps: production of cell lines expressing epitope-tagged bait
proteins, protein complex puriﬁcation and MS-based analysis
of the isolated samples. Each step contributes to the overall
performance of the process. To generate a robust and
reproducible workﬂow for the characterization of human
proteincomplexes,wehaveoptimizedeachstepandintegrated
them into an efﬁcient process. Thereby, we paid attention to a
goodcompatibilityofthestepsbetweeneachother.Thesystem
builds on (i) gateway-compatible orfeome collections and the
Flippase (Flp) recombination system to rapidly generate large
collections of human cell lines by homologous recombination
for isogenic and tetracycline (tet)-controlled expression of
tagged bait proteins, (ii) the development of a novel double-
afﬁnity puriﬁcation strategy to signiﬁcantly increase sample
recovery and reproducibility and (iii) direct liquid chromato-
graphy tandem mass spectrometry (LC-MS/MS) analysis of
puriﬁed complexes to improve the sensitivity of protein
identiﬁcation. In what follows we describe the individual steps
of the workﬂow and document its performance for systematic
proteincomplexanalysisasshownforthehumanPP2Aprotein
interaction network.
Rapid generation of cell lines for inducible
expression of afﬁnity-tagged bait proteins
A major bottleneck in large-scale AP-MS analyses in species
other than Saccharomyces cerevisiae has been the resource-
intense generation of cell lines expressing epitope-tagged bait
proteins, preferably at controlled levels, required for protein
complex puriﬁcation. Here, we combined recombinational
cloning of expression constructs from human orfeome
libraries with homologous recombination using Flp recombi-
nase in human cells to signiﬁcantly increase the production
rate for such human cell lines (Figure 1A). We used a gateway-
compatible orfeome collection containing 12212 ORFs, repre-
senting 10214 non-redundant protein-coding genes (Lamesch
et al, 2007) as a resource to generate expression constructs by
LR recombination with a destination vector suitable for
tetracycline-controlled expression of afﬁnity-tagged bait pro-
teins. The presence of a Flp recombination target site (FRT) in
the resulting expression constructs supported the rapid
generation of bait-expressing cell lines by Flp-mediated
recombination with a single FRT site present in the HEK293
host cell line (O’Gorman et al, 1991). The system was
evaluated with respect to the following properties. (i)
Efﬁciency and reliability. We routinely obtained isogenic
human HEK293 cell pools within 2 weeks after transfection
with a success rate of about 85% (n4200 transfected orf
clones, data not shown) without further need for subcloning.
(ii) Uniformity. The FRT recombination system ensures
uniform expression of the transgene in the respective cell
populations as demonstrated by indirect immunoﬂuorescence
microscopy of HEK293 cell lines expressing different epitope-
tagged proteins from the human PP2A system (Figure 1B). (iii)
Inducible bait expression. The ability to control bait protein
expression levels is crucial in cases in which growth inhibitory
or pro-apoptotic bait proteins are expressed. Expression levels
of bait proteins could be induced and adjusted by tetracycline
(Figure 1C) and were comparable with corresponding en-
dogenous protein levels (Figure 1D). In conclusion, orfeome-
based generation of human cell lines using the FRT system is
an efﬁcient and reliable method for the generation of large
collections of isogenic cell pools for tetracycline-controlled
expression of afﬁnity-tagged bait proteins at close to physio-
logical levels.
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Figure 1 Rapid generation of cell line collections for isogenic and inducible bait expression using Flp-recombinase-mediated recombination. (A) Schematic overview
on the generation of cell line collections. Starting from human Gateway orfeome collections, cDNAs of interest are recombined into an expression construct for
tetracycline (tet)-inducible expression of strep-hemagglutinin double-tagged (SH) bait proteins. Isogenic cell lines are generated using Flp-recombinase-mediated
recombinationthroughsingleFRTsitespresentintheexpressionconstructandthegenomeofFlp-InHEK293cellsstablyexpressingthetetrepressor.Aftertransfection,
cell lines are selected on hygromycin for 2 weeks, tested for tetracycline-inducible expression and used for subsequent afﬁnity puriﬁcation. (B) Isogenic bait protein
expression in HEK293 Flp-In cells. The expression of the indicated recombinant proteins in the absence or presence of 1mg/ml tetracycline for 24h was visualized by
indirect ﬂuorescence microscopy with an anti-HA antibody. Nuclei were stained with DAPI. (C) Tet-inducible bait expression. Increasing amounts of tetracycline were
addedtoHEK293cellsexpressingSH–eGFPfor24h.Baitexpressionwasmonitoredbyimmunoblottingusinganti-HAantibodies.(D)Comparisonofproteinexpression
levels of SH-tagged bait proteins with endogenous protein levels. HEK293 cell lines expressing SH-tagged bait proteins were analysed by immunoblotting using the
indicatedantibodiesfollowing inductionwithtetracycline(1mg/ml)for24h.HEK293cellsthatdonotexpressthecorresponding baitproteinswere usedascontrols.Note
that anti-PPP2C and anti-PPP2R1 antibodies do not distinguish between the highly related endogenous proteins PPP2CA and PPP2CB or PPP2R1A and PPP2R1B,
respectively.
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by SH-double afﬁnity puriﬁcation
So far, tandem afﬁnity puriﬁcation (TAP) has been the most
widely used procedure in systematic protein complex puriﬁca-
tion(Rigaut etal, 1999;Bouwmeesteret al,2004;Gingrasetal,
2005; Gavin et al, 2006). However, these studies required large
amounts of cellular starting material due to the low puriﬁca-
tion yields obtained by the TAP procedure (Al-Hakim et al,
2005; Gregan et al, 2007). This imposes signiﬁcant economical
and logistic challenges, especially for large-scale studies. To
improve the yield, we integrated a novel double-afﬁnity
puriﬁcation protocol into our analytical workﬂow. Protein
complexes are isolated through a small double-afﬁnity tag
(SH-tag) consisting of a streptavidin-binding peptide and a
hemagglutinin (HA) epitope tag. In addition, weoptimized the
puriﬁcation protocols for efﬁcient double-afﬁnity puriﬁcation
from low amounts of starting material. Following induction of
isogenic bait expression using tetracycline, SH-tagged and
associated proteins are ﬁrst bound to an afﬁnity column
containing a modiﬁed version of streptavidin (Junttila et al,
2005) and speciﬁcally eluted with biotin onto an anti-HA
antibody column. The protein complexes are eluted from this
column at low pH (Figure 2A). Western blotting showed that
SH-PPP2R2B from HEK293 cell extracts could be bound near
quantitatively to the streptavidin column (Figure 2B, SNS).
Elution from the streptavidin column with biotin was highly
efﬁcient with almost no detectable bait protein left on the
streptavidin beads following elution with SDS Laemmli buffer
(notshown).Overall,theﬁrstpuriﬁcationsteprecoveredmore
than90%ofbaitprotein(Figure2B,ES).Fromthewesternblot
signal intensity of the ﬁnal eluate (Figure 2B, EH), we estimate
L SNS ES SNH EH
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0.3 0.3 1.5 1.5 1.5 % Input
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strep purification
Second step
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Figure 2 Monitoring SH-double-afﬁnity puriﬁcation efﬁciency. (A) Schematic overview of the puriﬁcation procedure. HEK293 cells expressing SH-tagged proteins are
lysed and ﬁrst puriﬁed from total protein extracts using streptavidin sepharose (Strep-Tactin beads). After several wash steps, puriﬁed proteins are released in the
presence of 2mM biotin for subsequent immunoafﬁnity puriﬁcation using anti-HA agarose. Finally, protein complexes are eluted with 0.2M glycine, pH 2.5, and
processed for mass spectrometric analysis. (B) Western blot analysis of SH-puriﬁcation yields. SH-PPP2R2B expressing HEK293 cell line was generated as described
in Figure 1 and the puriﬁcation was performed on 3 10
7 cells. The puriﬁcation procedure was monitored by immunoblotting using anti-HA antibodies. L: lysate; SNS:
supernatant after streptavidin puriﬁcation; ES: elutionfrom the streptavidinsepharose; SNH: supernatant afteranti-HA puriﬁcation; EH: elutionfrom the anti-HA agarose
(ﬁnal eluate). Information on the percentage of input is given to compare the relative amount of sample loaded on each gel lane. (C) Reproducibility of SH-puriﬁcation
yields.11 cell lines inducibly expressing SH-tagged baitproteins related to the PP2A phosphatase system were generated asdescribed. Lysate (L) andﬁnal eluate(EH)
from all 11 bait-speciﬁc SH-puriﬁcations were immunoblotted using anti-HA antibodies and percentage of loaded sample amount is indicated.
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bait protein present in the cell lysate, which is among the
highest reported for double-afﬁnity puriﬁcation protocols.
Importantly, the high yields were achieved independent of the
bait protein, as SH-puriﬁcations of 11 different bait proteins
showed comparable yields (Figure 2C).
Monitoring speciﬁcity and sensitivity of the
SH-puriﬁcation
Protein complex preparations typically contain signiﬁcant
amounts of co-purifying contaminant proteins that increase
sample complexity, reduce the sensitivity of detection of true
interactors and complicate the interpretation of the results. We
ﬁrst monitored the sample complexity during the SH-puriﬁca-
tion step of our workﬂow by silver staining after biotin (ES)
and ﬁnal elution (EH) using the PP2A regulatory B subunit
PPP2R2B as a bait (Figure 3A). Biotin eluates contained high
molecular weight contaminants, which may interfere with the
identiﬁcation of less-abundant interaction partners by direct
LC-MS/MS. These contaminants were efﬁciently removed by
applying the second puriﬁcation step as shown by silver
staining and direct LC-MS/MS (Figure 3A, Supplementary
Table I).
In addition, we used the recently developed MasterMap
concept to illustrate the speciﬁcity increase achieved by the
second puriﬁcation step by monitoring the relative abundance
proﬁles of co-purifying proteins (Rinner et al, 2007). This
approach allows label-free protein quantiﬁcation from aligned
MS1 spectra obtained on a high mass accuracy instrument.
MS1 quantiﬁcation of the proteins identiﬁed with at least ﬁve
fully tryptic unmodiﬁed peptides revealed three major groups
of co-purifying proteins. (i) One set of proteins (Figure 3B, red
lines) was efﬁciently removed by the second puriﬁcation.
These proteins were also identiﬁed in SH–eGFP control
samples (Supplementary Table II) and include a group of
abundant carboxylases (e.g. MCCC1, PCCA, ACACA) that are
known to be biotinylated in vivo (Gravel and Narang, 2005),
and hence most likely interact with the streptavidin column
independent of the bait protein. (ii) A group of proteins
including HSP70 chaperones (HSPA5, HSPA6 and HSPA8) that
remained in the sample even after the second puriﬁcation step
(Figure 3B, orange lines). These proteins most likely represent
unspeciﬁc interactors that bind independently of the bait
protein, as they were also identiﬁed in eGFP control experi-
ments (Supplementary Table II). (iii) Finally, the group of
speciﬁc interactors that followed the proﬁle of the bait protein
but were absent in SH–eGFP control puriﬁcations. This group
contained well-established interactors of the bait protein
PPP2R2B, including PPP2R1A and PPP2R1B (Figure 3B,
yellow lines).
Previous systematic studies were hampered by the large
amount of cellular starting material required for AP-MS
analysis. We performed SH-puriﬁcations from as low as
4 10
6 HEK293 cells. Direct LC-MS/MS analysis of 25% of
the tryptic digest was still sufﬁcient to identify PPP2R2B-
interacting proteins PPP2CA, PPP2R1A and most of the
associated subunits of the CCTcomplex (Supplementary Table
III). As PP2A is regarded as an abundant phosphatase, we
recommend to use 3 10
7 cells for standard SH-puriﬁcation of
protein complexes.
Conclusively, the SH-double-afﬁnity puriﬁcation step is a
central part of our workﬂow and results in protein complex
preparations of high purity and, when combined with direct
LC-MS/MS, it signiﬁcantly reduces the amounts of cellular
starting material required for large-scale analysis.
Direct LC-MS/MS analysis
After cell line generation and afﬁnity puriﬁcation, the ﬁnal MS
analysis step represents another experimental bottleneck in
large-scale studies on protein complexes. Previous AP-MS
workﬂows used SDS–PAGE fractionation before MS analysis
(Gavin et al, 2006; Ewing et al, 2007). This, however,
multiplies the workload and time required for MS analysis,
as each band has to be analysed by an individual MS run.
Direct LC-MS/MS has poorly been exploited in previous high-
throughput AP-MS studies but can signiﬁcantly enhance
sensitivity and reduce instrument time of an AP-MS workﬂow,
as the entire afﬁnity-puriﬁed sample can be analysed by a
reversed-phase liquid chromatography unit coupled to a mass
spectrometer in one single step. For successful direct LC-MS/
MS analysis, samples have to be of moderate complexity,
meaning that the afﬁnity-puriﬁed protein complexes should
contain a minimum of contaminating proteins. This is
necessary because direct LC-MS/MS is prone to an under-
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Figure 3 Analysis of SH-double-afﬁnity puriﬁcation speciﬁcity. (A) Silver stain
monitoring of sample complexity. SH-double-afﬁnity puriﬁcation was performed
on 3 10
7 HEK293 cells expressing SH-PPP2R2B, and aliquots of the ﬁrst (ES)
and second (EH) puriﬁcation step were separated by SDS–PAGE. (B)
Quantitative MS analysis of the speciﬁcity increase by the second puriﬁcation
step. HEK293 SH-PPP2R2B lysates were split in half. Single and double-afﬁnity
puriﬁcations were performed as described before. Peptides derived from single
(ES) and double-afﬁnity puriﬁcation (EH) were mixed in a three-step dilution.
FollowingMS analysis, MS spectra were aligned andMS1 signal intensities were
used for relative quantiﬁcation to generate protein abundance proﬁles across the
three samples. All presented protein proﬁles were generated from aligned MS1
features that correspond to at least ﬁve unmodiﬁed, fully tryptic peptides. Note
that not all observed protein proﬁles were included here, as they did not pass the
indicated ﬁltering criteria (e.g. PPP2CA). Protein abundance proﬁles were
normalized to the bait proﬁle.Yellow lines correspond to speciﬁc bindingpartners
that match the bait proﬁle. Orange lines refer to unspeciﬁcally co-purifying
proteins identiﬁed also in SH–eGFP control samples. Proﬁles in red represent
proteins unspeciﬁcally co-puriﬁed with the streptavidin sepharose beads that are
successfullyremovedafterthesecondpuriﬁcationstep.Errorbarsindicates.e.m.
of MS1 feature ratios of the indicated proteins.
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more pronounced in complex samples (Liu et al, 2004).
Another prerequisite is the chemical compatibility of the
sample with the subsequent LC-MS/MS step. We adapted the
puriﬁcation strategy speciﬁcally to address these two points.
As described already above, SH-double-afﬁnity puriﬁcation
results in pure samples preparations with very little con-
taminant protein present. In addition, the second puriﬁcation
step efﬁciently removes detergent, protease inhibitors and
eluting reagents (e.g. biotin) present in the sample, which
would interfere with subsequent LC-MS/MS. Following tryptic
digest, the samples are desalted by a reversed-phase chroma-
tography step and directly loaded on a reversed-phase HPLC
column attached to an MS instrument for peptide separation
and MS analysis. The entire LC-MS analysis is completed
within 90min and thus signiﬁcantly increases sample
throughput.
Reproducibility of AP-MS data sets
Reproducibility of the data obtained by AP-MS is key to assess
the quality of protein interaction data sets but is poorly
addressed for existing AP-MS workﬂows performed in human
cells. We studied the overall reproducibility of protein
interaction data obtained by the method described here at
thenetworklevel.Forthis,weselected11ORFclonesencoding
proteins previously linked to the PP2A system and generated
isogenic HEK293 cell lines for their expression as SH-tagged
bait proteins (Figure 4A, upper panel). From each of these cell
lines, we performed two biological replicate SH-puriﬁcation
experiments and analysed each sample once by LC-MS/MS.
We identiﬁed a total of 185 proteins with at least one unique
peptide and a ProteinProphet probability 40.9 (Supplemen-
tary Table IV) (Nesvizhskii et al, 2003), which could be
mapped to 165 unique human entrez gene IDs. To eliminate
co-purifying contaminant proteins, wegenerated a database of
165 identified proteins
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Figure 4 Data processing and reproducibility of the overall workﬂow for a human PP2A protein interaction network. (A) HEK293 cell lines expressing 11 different bait
proteins linked previously to the human PP2A network were generated as described in Figure 1. Inducible expression was tested by western blotting (upper panel).
Eleven cell lines were used for two independent SH-double afﬁnity puriﬁcation experiments directly followed by LC-MS/MS (SH-LC-MS/MS). Obtained mass spectra
were analysed with XTandem followed by statistical validation of the search results using PeptideProphet and ProteinProphet. Only proteins with minimum
ProteinProphet probabilities of 0.9 were considered. Primary interaction data were ﬁltered against a contaminant database resulting in a ﬁnal list of 242 (replicate A) and
218 (replicate B) bait–prey interactions with an overlap of 85%. To assess the reproducibility rate, the sum of common interactions found in experiments A and B were
dividedbythetotalnumberofinteractionsidentiﬁed.(B)Generationofadatabasecontainingco-purifyingcontaminant proteinsusedfordataﬁltering.Eightindependent
control puriﬁcations were performed using SH-tagged eGFP as a bait protein. Tryptic peptides were analysed twice by LC-MS/MS and identiﬁed proteins from all 16
measurements were consecutively added to a contaminant database. A total of 109 proteins were identiﬁed and used to subtract unspeciﬁc protein contaminants.
(C) Robustness of protein interaction data obtained by the integrated workﬂow. The number of protein interactions (black line) and the percent overlap (red line) across
the two replicate data sets shown as a function of increased ﬁltering stringency (number of unique peptides required for protein identiﬁcation).
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puriﬁcations analysed by 16 LC-MS/MS experiments,
which yielded an exhaustive list of 109 contaminant
proteins (Figure 4B, Supplementary Table II). Proteins
identiﬁed in bait-speciﬁc experiments that were also present
in the contaminant database were considered as unspeciﬁc
binders and removed from the data set (Supplementary
Table V). As ribosomal proteins represent a major group
within the contaminant database, we also eliminated
all ribosomal proteins as well as keratins introduced
during the procedure (for details, see Supplementary
Table V). This resulted in a ﬁnal list of 108 proteins speciﬁcally
associated with the selected group of bait proteins and
resulted in 242 and 218 bait–prey interactions identiﬁed in
replicate experiments A and B, respectively (Figure 4A,
Supplementary Table VI). We found 197 overlapping interac-
tions in the two experiments, which correspond to an overall
reproducibility rate of 85%. This is among the highest rates
reported so far for systematic AP-MS/MS workﬂows (Gavin
et al, 2006).
Applying more stringent ﬁltering criteria by increasing
the numbers of unique peptides required for protein
identiﬁcation from 1–4 only marginally increased the overlap
from 85 to 92%, but at the same time resulted in a signiﬁcant
decrease (33%) of identiﬁed interactions (Figure 4C). To
increase the robustness of the ﬁnal PP2A protein network
model, we considered only protein–protein interactions
observed in both biological replicate experiments. The
high quality of the ﬁnal network allowed us to identify
small but signiﬁcant differences in the connectivity of closely
related proteins. This is illustrated by the data obtained from
the two highly connected catalytic subunits PPP2CA and
PPP2CB, which share 97% amino-acid sequence identity. All
the 28 interacting proteins that we identiﬁed in PPP2CA
puriﬁcations were also found in the group of 32 PPP2CB-
associated proteins. The additional four PPP2CB interacting
proteins comprise members of the human prefoldin family,
indicating that PPP2CB may be linked to the prefoldin
complex.
It has been proposed that interactions between two proteins
are of higher conﬁdence if the interactions also occur between
the corresponding paralogous proteins (Deane et al, 2002).
Within the 197 interactions identiﬁed here, we found 150
interactions for which at least one paralogous interaction was
found in our data set (Supplementary Table VII), which
serves as an indicator of the achieved data quality and hints at
a high degree of combinatorial complex formation by
paralogous interactions within the identiﬁed phosphatase
network. To further validate the data quality, we also
compared the interaction data from this study with the
existing information from the literature and published
databases. Of the 197 interactions identiﬁed here, 69 have
been reported previously. Among the remaining 128 interac-
tions,wefound 30paralogous and 32 orthologous interactions
described previously in humans or yeast, respectively
(Figure 5, Supplementary Table VIII). Collectively, these
results showed that the method described here provides
speciﬁc and highly reproducible interaction data sets suited
for the generation of robust models of human protein
interaction networks.
A network of human PP2A complexes
The obtained 197 protein interactions are derived from the
puriﬁcation of coexisting phosphatase protein complexes.
When the data are assembled into a protein interaction
network model, it is, however, difﬁcult to reconstruct the
composition of the underlying protein complexes solely from
thetopologyoftheresultingnetworkmodel,unlessinteraction
proteomeshavebeen mappedclosetosaturationasithasbeen
shownfortheyeastproteome(Gavinetal,2006).Inthecaseof
the human PP2A phosphatase, however, signiﬁcant amount of
information on the biochemistry and structure of PP2A core
complexes have been reported over the past two decades.
This information can be used to map the obtained protein
interaction data to the corresponding paralogous interactions
of known PP2A complexes. This allowed us to assign the
protein interactions to groups of related complexes (referred
to as modules) and determine which types of the PP2A
complexes coexist and can be observed in human embryonic
kidneycellsbyourapproach.Wefoundatleastﬁvemodulesof
related phosphatase complexes within the obtained network
(Figure 6).
PP2A core module
First, we noted a highly connected triangular subnetwork
formed between catalytic C, scaffolding A and regulatory B
subunits of PP2A. All of the regulatory B subunits were found
in association with both the catalytic as well as the scaffolding
A subunits of PP2A. No interactions were found between the
different catalytic subunits or among the various scaffolding A
or the regulatory B subunits. The observed topology is in
agreement with literature information and the previously
established X-ray structural model on the trimeric PP2A
complex (Chao et al, 2006; Xu et al, 2006; Cho and Xu,
2007). These data therefore suggest the coexistence of a large
number of heterotrimeric PP2A core complexes, each consist-
ing of a catalytic, a scaffolding A and a regulatory B subunit
(Figure 6, PP2Acore module), which represent the majority of
Unknown
Related interaction known in yeast
Related interaction known in human 
Known
66
32
69
30
Figure 5 Summary of the identiﬁed protein interaction data set. A total of 197
protein–protein interactions identiﬁed in this study have been grouped according
to available literature information into known interactions, homologous
interactions identiﬁed in either human or yeast or unknown protein interactions.
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plexes appear to be connected primarily through the regula-
tory B subunits to a variety of cellular proteins with functions
in cell cycle control, mitosis, transcription and more (see also
discussion).
PP4 module
Interestingly, we found regulatory PP2A subunits (PPP2R2D,
PPP2R1A and PPP2R5D) also in complexes with PPP4C, the
catalytic subunit of the serine/threonine protein phosphatase
4 (PP4). This suggests a certain degree of interchangeable
subunit assembly between these two phosphatase systems.
When we subsequently used PPP4C as a bait, we also
identiﬁed proteins exclusively associated with PPP4C repre-
senting the second group of phosphatase complexes found in
thisstudy(Figure6,PP4complexes).Thesecomplexescontain
the PP4 regulatory proteins PPP4R1 and PPP4R2 as well as
proteins linked to DNA damage control, such as SMEK1,
SMEK2 and CCDC6 (Gingras et al, 2005; Merolla et al, 2007),
that were absent in the other PP2A complexes analysed.
Furthermore, we identiﬁed a novel PPP4C-associated protein,
KIAA1622, that is characterized by the presence of HEATand
armadillo-like domains. As the same domains are also present
in the known phosphatase-scaffolding subunits of PP4 and
PP2A, KIAA1622 may represent a novel scaffolding subunit of
PP4 complexes.
Striatin module
We were able to identify a highly connected PP2A subnetwork
when using PPP2CA, PPP2CB, PPPR1A and PREI3 (human
homologue of yeast Mob1) as bait proteins. Besides a speciﬁc
class of regulatory B subunits referred to as the striatins (Strn,
Strn3, Strn4), this subnetwork contains the serine/threonine
protein kinase MST4, the protein SLMAP as well as speciﬁc
groups of structurally related proteins (FAM40A, FAM40B;
CTTNBP2, CTTNBP2NL; SIKE, FGFR1OP2). The remarkable
connectivity among members of this subnetwork provides
evidenceforagroupofhigher-orderPP2Acomplexes(Figure6,
striatin module).
IGBP1/alpha4 module
We identiﬁed the protein IGBP1 (also referred to as alpha4),
the human homologue of yeast TAP42, exclusively in PPP2CA,
PPP2CB and PPP4C puriﬁcations (Figure 6, IGBP1/alpha4
module). This is in agreement with the present model that
IGBP1/alpha4 forms complexes with catalytic subunits in the
absence of scaffolding A or regulatory B subunits (Saleh et al,
2005). IGBP1/alpha4 was shown to be required for such
diverse processes as maintenance of cell survival (Kong et al,
2004) as well as learning and memory (Yamashita et al, 2006).
PPME1 module
This module is characterized by the presence of the protein
phosphatase methylesterase 1 (PPME1), which we have found
associated speciﬁcally with the catalytic as well as scaffolding
subunits of PP2A. PPME1 is crucial for the demethylation of
the C-terminal L309 of the PP2A catalytic subunit, which is
part of a complex mechanism for the control of PP2A activity
(Longin et al, 2004; Hombauer et al, 2007).
When we mapped our interaction data to the available
orthologous interaction data in yeast, we noticed that the
interactions within these ﬁve modules are highly conserved
Others
Methyesterase
Prey
Bait
PP2A core module
PP4 module
Striatin module
IGBP1/alpha4 module
PPME1 module
Known interaction
Unknown interaction
Scaffolding subunit
Regulatory subunit
Catalytic subunit
CCT/PFD subunits
Figure6 Protein–proteininteractionsanddifferentclassesofproteincomplexeswithinthehumanPP2Ainteractionnetwork.Protein–proteininteractiondataidentiﬁed
intwooutoftworeplicateexperimentswerevizualizedusingCytoscapev.2.5.1.Baitproteinsarerepresentedastriangles,andpreyproteinsarerepresentedasrounded
squares.Nodeswereclassiﬁedaccordingtothelegend.Edgecolourindicatesknowninteractions(orange)ornewlyidentiﬁedinteractions(blue).Thicknessoftheedges
reﬂects the number of identiﬁed unique peptides. Five classes of PP2A protein complexes could be distinguished on the basis of network topology and literature
information and are displayed by dotted lines and colour shading (see legend).
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that the number of PP2A regulatory subunits and their
interaction with PP2A has expanded in the human system,
whereas the number of PP2A catalytic subunits remained
constant in human and yeast cells (Figure 7).
In conclusion, the proposed integrated workﬂowallowed us
to assemble the most comprehensive protein network model
for human PP2A known to date. The results conﬁrm and
signiﬁcantlyextendour knowledge ona remarkablemolecular
principle underlying the functional diversiﬁcation of a human
phosphatasesystembydifferentialproteincomplexformation.
Discussion
Here, we present an integrated workﬂow for the systematic
analysis of human protein complexes. This workﬂow, when
compared with previous methods, has the following favour-
able properties: (i) it signiﬁcantly saves resources, labour and
time for the systematic generation of cell lines for inducible
expression of afﬁnity-tagged bait proteins; (ii) it has improved
sensitivity and thus minimizes the sample amounts required
for the successful isolation and analysis of protein complexes;
and (iii) it generates protein interaction data of unprecedented
reproducibility in human cells suited for data integration in
systems biology.
Rapid and reliable production of human cell lines
for systematic AP-MS studies
In contrast to studies in yeast where site-speciﬁc recombina-
tion has facilitated the generation of strains expressing speciﬁc
afﬁnity-tagged proteins at high throughput, the production
of the corresponding human cell lines has been a critical
bottleneck for systematic AP-MS studies. Generation of cell
lines in previous studies involved many steps (e.g. PCR
cloning, sequencing, selection and testing of cell clones and so
on) and consumed signiﬁcant amounts of resources and time.
In addition, the level of bait expression could not be adjusted,
which may result in massive protein overexpression of the
bait protein.
In the presented method, we used Flp-mediated recombina-
tion of speciﬁc cDNAs from an orfeome resource for rapid
generation of large collections of cell lines. This takes
advantage of the rapidly expanding collections of human
cDNAs and thus obviates the need for PCR cloning and
sequencing. Many of the steps for gateway recombination can
be carried out by liquid handling robots and require only a
minimum amount of work compared with classical cloning.
Starting from an orfeome entry clone, isogenic cell pools for
inducible bait expression are reliably obtained within 2–3
weeks, which is signiﬁcantly less than the time needed with
previous methods. In contrast to previous studies, which were
almost exclusively performed by industrial labs or large
academic consortia (Bouwmeester et al, 2004; Ewing et al,
2007), our procedure will enable also academic labs with
limited personnel resources to conduct high-quality AP-MS
studies onalargerscale.Inducibleexpressionasappliedinour
method signiﬁcantly expands the range of bait proteins that
can be analysed in large-scale AP-MS studies, as cell lines
expressing growth-inhibitory and pro-apoptotic bait proteins
can now be generated. Importantly, tunable expression of bait
proteins from a deﬁned genomic locus as presented here
allowsequalbaitexpressionatphysiologicallevelsthroughout
the cell population. This reduces the rate of false-positive
interactions caused bymassiveoverexpression of bait proteins
typically observed in stably or transiently transfected cell lines
using constitutive promoters. Collectively, these advances will
signiﬁcantly improve data quality and expand the scope of
future large-scale AP-MS studies in human cells.
Homo sapiens Sacharomyces cerevisiae
Figure 7 Evolutionary conservation of protein interactions within the PP2A network. Interaction data from this study for which the corresponding orthologous protein
interactions could be found in yeast are displayed as a network graph and compared with the yeast PP2A network. Human gene symbols and yeast gene names have
been used as node identiﬁers. Dotted red lines indicate the orthology relationships between the shown network components. Note the expansion of orthologous
interactions involving regulatory subunits (dark blue nodes) in the human PP2A system.
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Another bottleneck in previous large-scale protein complex
analysis is linked to the limited overall sensitivities of
previous workﬂows, which require massive amounts of
cellular starting material in the range of 1 10
8–1 10
9 cells
(Al-Hakim et al, 2005; Gregan et al, 2007). This, in turn,
imposes signiﬁcant problems for high-throughput AP-MS
studies with respect to available resources and experimental
logistics.OverallsensitivityinAP-MSworkﬂowsisdetermined
byboththeproteincomplexpuriﬁcationprocedureandtheMS
analysis step. We introduce a strategy using a streptavidin-
binding peptide combined with the hemagglutinin epitope
(SH) for the complex puriﬁcation step in our integrated
workﬂow. The SH-tag consists of 48 amino acids, which is
signiﬁcantly smaller than the 21kDa TAP tag and allows
efﬁcient double-afﬁnity puriﬁcation with high speciﬁcity.
Using various bait proteins, we typically obtained
overall puriﬁcation yields between 30 and 40%. These yields
are considerably higher than the ones obtained with the
classical or the recently improved version of the TAP tag
procedure (Burckstummer et al, 2006). The signiﬁcant
improvements in puriﬁcation yield can be attributed
to both the efﬁcient binding as well as efﬁcient elution from
the two different afﬁnity reagents. The elimination of the
TEV cleavage step applied in the classical and modiﬁed
TAP procedures also accounts for the enhanced yields and
overall puriﬁcation speed (2–3h). SH-puriﬁcation yielded
complex preparations of high purity suitable for direct LC-
MS/MS analysis. This obviates the multiple experimental
steps associated with gel-based MS procedures to enable
comprehensive protein identiﬁcation at high throughput
from reduced sample amounts. As a result, the combined
SH-LC-MS/MS approach allows the identiﬁcation of speciﬁc
complex partners from minimal analyte amounts that
correspond to 1 10
6 cells. Obviously, more starting material
increases the chance to identify also complex components of
low abundance. We recommend using around 3 10
7 cells
for the proposed procedure, which yields enough material
for multiple LC-MS/MS experiments and identiﬁcation
of even substoichiometric components. This amount is about
10 times lower than the amounts used by other workﬂows
(Al-Hakim et al, 2005; Burckstummer et al, 2006; Gregan et al,
2007).
Reproducibility and data robustness
Clearly reliable models on human protein interaction net-
works at a global scale can only be accomplished as a
collective effort by the research community, given the
enormous resources involved in this task. This, in turn, will
dependonanalyticalprocedures,whichminimizetheproblem
of false-positive identiﬁcation and provide a high level of data
robustness.
Co-purifying contaminant proteins are a major source for
false-positive interactions. As we show, the SH-puriﬁcation
step in our pipeline allows efﬁcient removal of many of these
contaminants. Contaminants that still remained after double-
afﬁnity puriﬁcation were efﬁciently removed from the
interaction data sets using a contaminant database obtained
from multiple SH–eGFP control puriﬁcations as a ﬁlter.
Dataqualityinlarge-scaleAP-MSstudieslargelydependson
the reproducibility of the applied experimental strategy.
However, very little is known on the overall reproducibility
rates of AP-MS workﬂows at present used for systematic
protein complex analysis. To our knowledge, the only reliable
source of information was given in a report on the gel-based
TAP-MS approach used to study the compendium of yeast
complexes, which refers to an overall reproducibility of
69% (Gavin et al, 2006). To address this point, we used the
presented workﬂow to analyse a network of human phospha-
tasecomplexesin duplicatesand found that atleast 85% ofthe
identiﬁed interaction data overlap between two replicate
experiments, which represents a signiﬁcant advance for future
AP-MS studies.
Modularity of a human phosphatase network
Over the past two decades, a considerable amount of
biochemical and structural data have been reported on
PP2A complexes from different species. These data serve as
a valuable resource to determine whether the new high-
throughput method can generate validated new biological
information. The SH-LC-MS/MS analysis showed the most
comprehensive phosphatase protein–protein interaction
network model known to date. It consists of 69 protein–
protein interactions that were already reported in the
published literature and 128 novel interactions, 62 of
which were related to previously known interactions
(Supplementary Table VIII). The signiﬁcant overlap with
published information again highlights the reliability of the
presented analytical AP-MS approach and illustrates its
potential to retrieve new biological information. In the case
of the studied phosphatase network, this approach showed
important insights into the overall modular organization of a
human phosphatase system and provided promising clues
about the molecular functions of the studied phosphatase
complexes.
The network topology obtained by the presented
method combined with available literature information
showed all major types of PP2A complexes, including the
previously described non-canonical PP2A complexes
containing alpha4 or the protein phosphatase methylesterase
as well as the canonical heterotrimeric PP2A core complexes
that account for the majority of PP2A assemblies we
have identiﬁed. It is thought that the majority of these
canonical PP2A complexes function as heterotrimeric
assemblies. Using our analytical method, we could uncover
that also higher-order complexes can be formed around
these core complexes in human cells. The presented work
showedahighlyconnectedPP2Asubnetwork,whichindicates
a novel type of higher-order PP2A complexes in human cells
(Figure 6). These complexes are formed by a characteristic set
of cellular proteins around a canonical heterotrimeric PP2A
core complex that contains a speciﬁc group of regulatory B
subunits referred to as striatins besides catalytic and scaffold-
ing subunits.
For some of the phosphatase subunits, the nature of
associated proteins identiﬁed in this study provide important
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demonstrated for the following three examples. (i) PREI3, a
central component of novel striatin complexes described
above, for example, associates with the serine/threonine
kinase MST4, a Ste20-related kinase that mediates cell growth
control through the ERK pathway (Lin et al, 2001). In
this context a recent large-scale AP-MS study has identiﬁed
the related kinase MST3 associated with proteins of the
striatin complex (PREI3, STRN, STRN3), which may point
at a novel functional link between PP2A and a subset of
Ste20-related kinases (Ewing et al, 2007). (ii) In protein
phosphatase 4 complexes, we identiﬁed SMEK1 and SMEK2
(also referred to as PP4R3a and PP4R3b), two proteins
with functions in DNA damage control that have been
linked previously to PP4 (Gingras et al, 2005). In this study,
in addition we found CCDC6 as a component of PP4
complexes. CCDC6 has been recently linked to the ATM-
dependent DNA damage–response pathway (Merolla et al,
2007), which together with the previous results indicates a
more general function for PP4 in human DNA damage
control. (iii) A subset of PP2A-associated proteins may link
PP2A to the control of kinetochore function during mitosis.
Among them are SKA1 and SKA2, two novel PP2A-associated
proteins that we have identiﬁed in complexes with the PP2A
regulatory B subunit PPP2R2B. SKA1 and SKA2 are known to
bind each other, localize to the kinetochores and have a
suggested function in spindle checkpoint silencing (Hanisch
et al, 2006). Similarly, the known PP2A-associated protein
shugoshin, which we identiﬁed also in PP2A complexes, is
localizedalsoatkinetochoresandhasanimportantfunctionin
the control of sister chromatin segregation (Salic et al, 2004;
Kitajimaetal,2006).Thesefewexamples,whichhighlight just
a subset of the molecular linkages presented in this study,
illustrate how the data obtained by the proposed procedure
can be used to develop new hypotheses. When compared with
the available yeast interaction data, we noted a high degree of
overlap between the interactions that constitute the ﬁve
modules that we found in our network, indicating that these
phosphatase modules have evolved relatively early during
eukaryotic evolution (Figure 7). Interestingly, it appears that
expansion in particular of the regulatory B subunits and
theirspeciﬁcinteractionwithothercellularproteinsrepresents
a major step to increase the regulatory opportunities by
the PP2A network in multicellular eukaryotes, as the number
of PP2A catalytic subunits appear to be the same in humans
and yeast.
Systems-oriented concepts on the regulation of biological
processes in health and disease are among the major
goals in post-genomic biomedical research. Large-scale
AP-MS studies will have a central function in this
effort, as it is the only method to retrieve global information
on how proteins are organized into systems of functionally
interacting complexes. This knowledge will be essential
to understand the dysfunction of cellular systems in
pathological situations and to propose novel routes for
interfering with deregulated cellular processes. We are
convinced that the advances in throughput, sensitivity and
reproducibility collectively achieved by the workﬂow
described here mark a signiﬁcant step forward towards
these goals.
Materials and methods
Generation of expression constructs
and tetracycline-inducible cell lines
To generate expression vectors for tetracycline-controlled expression
of N-terminally SH-tagged versions of bait proteins, human ORFs
provided as pDONR223 vectors were selected from a Gateway-
compatible human orfeome library (horfeome v3.1, Open Biosystems)
for LR recombination with the in-house-designed destination vector
pcDNA5/FRT/TO/SH/GW, which we obtained through ligation of the
SH-tag coding sequence and the Gateway recombination cassette into
the polylinker of pcDNA5/FTR/TO (Invitrogen).
Flp-In HEK293 cells (Invitrogen) containing a single genomic FRT
site and stably expressing the tet repressor were cultured in DMEM
(4.5g/l glucose, 10% FCS, 2mM L-glutamin, 50mg/ml penicillin,
50mg/ml streptomycin) containing 100mg/ml zeocin and 15mg/ml
blasticidin. The medium was exchanged with DMEM medium
containing 15mg/ml blasticidin before transfection. For cell line
generation, Flp-In HEK293 cells were co-transfected with the
correspondingexpression plasmidsandthe pOG44 vector (Invitrogen)
for coexpression of the Flp-recombinase using the Fugene transfection
reagent (Roche). Two days after transfection, cells were selected in
hygromycin-containing medium (100mg/ml) for 2–3 weeks and
inducible bait expression was tested by immunoblotting using anti-
HA antibodies (Covance). Antibodies for detection of endogenous
PPP2R1, PPP2C, STK3 and AMPKa1 were obtained from Cell
Signalling Technologies. Tubulin antibodies were obtained from
Sigma, and TIP49 antibodies were prepared as described previously
(Gstaiger et al, 2003).
Indirect immunoﬂuorescence microscopy
HEK293 cells inducibly expressing SH-tagged bait proteins were
seeded on human ﬁbronectin-coated glass coverslips (Becton Dick-
inson) and grown in DMEM containing 10% FCS. Cells were washed
once in PBS before ﬁxation for 15min in 4% paraformaldehyde/PBS.
Fixed cellswerewashedoncewithPBS containing100mMglycineand
twice with PBS. Fixed cells were treated for 2min with 0.5% Triton/
PBS. Following two washes with PBS, cells were incubated with a
1:1,000 dilution of a monoclonal anti-HA monoclonal antibody (HA-
11, Covance) for 1h. Cells were washed three times with PBS and
stained with a 1:400 dilution of an anti-mouse-Alexa488 secondary
antibody (Invitrogen) and 40,6-diamidino-2-phenylindole (DAPI).
Finally, cells were washed three times with PBS and mounted in
Vectashield (Vector Laboratories), and images were obtained on a
Leica DM5500 Q microscope.
SH-double-afﬁnity puriﬁcation of protein
complexes
Bait expressing Flp-In HEK293 cells were lysed in TNN-HS lysis buffer
(0.5% NP40, 50mM Tris–HCl, pH 8.0, 250mM NaCl, 50mM NaF,
1.5mM NaVO3, 5mM EDTA, 1mM DTT, 0.5mM PMSF and protease
inhibitor cocktail (Sigma)). Insoluble material was removed by
centrifugation. The cleared lysate was loaded consecutively on spin
columns (Bio-Rad) containing 200ml Strep-Tactin beads (IBA Tagnol-
ogies)andthebeadswerewashedfourtimeswithﬁvebeadvolumesof
TNN-HS lysis buffer. Proteins were eluted from the Strep-Tactin beads
with ﬁve bead volumes of 2mM biotin. The eluate was then incubated
with 100ml anti-HA agarose (Sigma) for 2h at 41C on a rotation shaker.
Immunoprecipitates were washed four times with 10 bead volumes of
TNN-HS lysis buffer and two times with 10 bead volumes of the
corresponding lysis buffer in the absence of protease inhibitor and
detergent. By adding ﬁve bead volumes of 0.2M glycin, pH 2.5,
proteins were eluted and subsequently neutralized with 100mM
NH4HCO3.Cysteinebondswerereducedwith5mMTCEPfor30minat
371C and alkylated in 10mM iodacetamide at room temperature.
Samples were digested by adding 1mg trypsin (Promega) overnight at
371C. The peptides were puriﬁed using C18 microspin columns
(Harvard Apparatus) according to the protocol of the manufacturer,
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mass spectrometer.
LC-MS/MS analysis
LC-MS/MS analysis was performed using an Agilent 1100 series pump
(Agilent Technologies, Waldbronn, Germany) and an LTQ mass
spectrometer (Thermo Electron, Bremen, Germany). The setup of
the mRPLC system and the capillary column were described previously
(Yietal,2003).Theelectrosprayvoltagewassetto1.8kV.Thesamples
were loaded from the Agilent auto sampler onto the precolumn at a
ﬂ o wr a t eo f4ml/min in 5min. Mobile phase A was 0.1% formic acid
and mobile phase B was 100% acetonitrile (Sigma, Buchs, Switzer-
land).Foranalysis,aseparatinggradientfrom5to45%mobilephaseB
over 40min at 0.2ml/min was applied. The three most abundant
precursor ions in each MS scan were selected for CID if the intensity of
the precursor ion exceeded 20000 ion counts. Dynamic exclusion
window was set to 2min. To prevent cross-contamination between the
different samples, the LC system was washed with a pulse of 8ml
triﬂuoroethanol (Fluka, Buchs, Switzerland) after every sample. A
peptide standard containing 200fmol of [Glu1]-Fibrinopeptide B
human (Sigma, Buchs, Switzerland) was analysed by LC-MS/MS to
constantly monitor the performance of the LC-MS/MS system.
Samples that were subjected to label free quantiﬁcation were analysed
on a high performance LTQ-FT-ICR mass spectrometer (Thermo
Electron, Bremen, Germany), which was connected online to a
nanoelectrospray ion source (Thermo Electron, Bremen, Germany).
Peptide separation was carried out using an Eksigent Tempo Nano LC
System (Eksigent Technologies, Dublin, CA, USA) equipped with an
RP-HPLC column (75mm 15cm) packed in-house with C18 resin
(Magic C18 AQ 3mm; Michrom BioResources,Auburn, CA, USA) using
a linear gradient from 96% solvent A (0.15% formic acid, 2%
acetonitrile) and 4% solvent B (98% acetonitrile, 0.15% formic acid)
to 25% solvent B over 60min at a ﬂow rate of 0.3ml/min. The data
acquisition mode was set to obtain one high-resolution MS scan in the
ICR cell at a resolution of 100000 full-width at half maximum (at m/z
400) followed by MS/MS scans in the linear ion trap of the three most
intenseions(overallcycletimeof1s).ToincreasetheefﬁciencyofMS/
MS attempts, the charged state screening modus was enabled to
exclude unassigned and singly charges ions. Only MS precursors that
exceeded a threshold of 150 ion counts were allowed to trigger MS/MS
scans. The ion accumulation time was set to 500ms (MS) and 250ms
(MS/MS) using a target setting of 10
6 (for MS) and 10
4 (for MS/MS)
ions. After every sample, a peptide mixture containing 200fmol of
[Glu1]-Fibrinopeptide B human (Sigma, Buchs, Switzerland) was
analysed by LC-MS/MS to constantly monitor the performance of the
LC-MS/MS system. All raw data have been made publicly accessible
through the PeptideAtlas database (http://www.peptideatlas.org/
repository/publications/Glatter2008/).
MS2 peptide assignments and MS1 alignment
Acquired MS2 scans were searched against the human International
ProteinIndex(IPI)proteindatabase(v.3.26)usingtheXTandemsearch
algorithm (Craig and Beavis, 2004) with k-score plug-in (MacLean
et al, 2006). In silico trypsin digestion was performed after lysine and
arginine (unless followed by proline) in fully tryptic peptides. Allowed
monoisotopic mass error for the precursor ions was 3Da for the LTQ
data and 50p.p.m. for the FT data. A ﬁxed residue modiﬁcation
parameter was set for carboxyamidomethylation (þ57.021464Da) of
cysteine residues. Oxidation of methionine (þ15.994915Da) was set
as variable residue modiﬁcation parameter. Model reﬁnement para-
meters were set to allow phosphorylation (þ79.966331Da) of serine,
threonine and tyrosine residues as variable modiﬁcations. Further-
more, semi-tryptic peptides were allowed for reﬁnement searches. For
scoring, a maximum of two missed cleavages were considered. Search
results were evaluated on the Trans Proteomic Pipeline (TPP v3.2)
using PeptideProphet (Keller et al, 2002) and ProteinProphet (Nes-
vizhskii et al, 2003; Keller et al, 2005). For label-free quantiﬁcation,
samples were analysed on an LTQ-FT-ICR instrument and MS1
alignment was performed using Superhirn (Mueller et al, 2007; Rinner
et al, 2007). Protein intensity proﬁles were normalized using the
averagelog2 (Ii
(1,2 or 3))/(Ii
(1))(Ii
(j)¼ionintensityoffeatureiindilutionj)
over features belonging to the same protein and normalized to the bait
protein proﬁle.
Analysis of protein interaction data
Protein identiﬁcations with ProteinProphet probabilities o1 were
subjected to manual inspection to exclude misassigned protein
identiﬁcations. Protein IDs were ﬁltered against a contaminant
database obtained from a total of eight independent SH–eGFP control
puriﬁcations analysed by 16 LC-MS/MS experiments and mapped to
non-redundantentrezgeneIDs.Interactiondatafromtwoindependent
replicates were compared and interactions found in both replicates
were used for assemblyof protein–protein interaction network models
using Cytoscape 2.5.1 (www.cytoscape.org). All interaction data have
been made publicly accessible through the IntAct protein interaction
database (http://www.ebi.ac.uk/intact/site/index.jsf). To identify
known interactions, an in-house database containing 61263 interac-
tionsfromvariousdatabases(BIND,DIP,IntAct,HPRD)andpublished
literature (Ramani et al, 2005; Rual et al, 2005;Stelzl et al, 2005;Ewing
et al, 2007) was used. Orthology data have been retrieved from the
Ensemble database (version from 16 Sep 2008) using biomart version
0.7 (http://www.biomart.org). Interaction data from yeast have been
downloadedfromthe biogridserverhttp://www.thebiogrid.org(Stark
et al, 2006) and Cytoscape 2.5.1 was used for mapping orthologous
interactions.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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